Trailing-twelve-month (TTM) revenue is $3.14 Billion with a year-over-year growth of +5.01%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $768,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-29 |
| Q4 FY2025Period ended 2025-12-31 | $778,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-18 |
| Q1 FY2026Period ended 2026-03-31 | $782,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $806,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $3,136,000,000 |
Current P/S: $22,933,490,548 market capitalization ÷ $3,136,000,000 TTM revenue = 7.31x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $806.30M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:16:12.045Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Energy and Specialized Markets | $642M | $649M | $22M | N/A | N/A | N/A |
| Financial Services | $157M | $143M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Other Countries | $469M | $509M | $207M | $253M | $281M | $300M |
| UNITED KINGDOM | $182M | $204M | $170M | $190M |
$3.14B
$3.14 Billion
+5.01%
vs. $2.99B a year ago (TTM)
+1.65%
5 Year compound annual growth rate
1 Year
+5.01%
3 Year
+13.12%
5 Year
+1.65%
10 Year
+4.49%
15 Year
+6.49%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.07B | +$191.00M | +6.63% |
| 2024 | $2.88B | +$200.30M | +7.47% |
| 2023 | $2.68B | +$184.40M | +7.38% |
| 2022 | $2.50B | +$34.50M | +1.40% |
| 2021 | $2.46B | +$193.10M | +8.51% |
| 2020 |
TTM Growth
+5.01%
3-Year CAGR
+13.12%
5-Year CAGR
+1.65%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:16:12.045Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Insurance | $2.0B | $2.2B | $2.4B | $2.7B | $2.9B | $2.2B |
|---|
| $214M |
| $250M |
| UNITED STATES | $2.1B | $2.3B | $2.1B | $2.2B | $2.4B | $2.5B |
|---|
| $2.27B |
| ($337.70M) |
| (12.95%) |
| 2019 | $2.61B | +$212.00M | +8.85% |
| 2018 | $2.40B | +$249.90M | +11.65% |
| 2017 | $2.15B | +$150.00M | +7.52% |
| 2016 | $2.00B | +$234.50M | +13.32% |
